Literature DB >> 12960225

Generation and characterization of mice transgenic for human IL-18-binding protein isoform a.

Giamila Fantuzzi1, Nirmal K Banda, Carla Guthridge, Andrea Vondracek, Soo-Hyun Kim, Britta Siegmund, Tania Azam, Joseph A Sennello, Charles A Dinarello, William P Arend.   

Abstract

Interleukin (IL)-18 binding protein (IL-18BP) is a natural inhibitor of the pleiotropic cytokine IL-18. To study the role of IL-18BP in modulating inflammatory responses in vivo, mice transgenic for human IL-18BP isoform a (IL-18BP-Tg) were generated. The transgene was expressed at high levels in each organ examined. High levels of bioactive human IL-18BPa were detectable in the circulation of IL-18BP-Tg mice, which were viable, fertile, and had no tissue or organ abnormality. The high levels of IL-18BP in the transgenic mice were able to completely neutralize the interferon-gamma (IFN-gamma)-inducing activity of exogenously administered IL-18. Following administration of endotoxin, with or without prior sensitization with heat-inactivated Propionibacterium acnes, IL-18BP-Tg mice produced significantly lower serum levels of IFN-gamma and macrophage-inflammatory protein-2 compared with nontransgenic littermates. Significantly reduced production of IFN-gamma in response to endotoxin was also observed in cultures of IL-18BP-Tg splenocytes. Finally, IL-18BP-Tg mice were completely protected in a model of hepatotoxicity induced by administration of concanavalin A. These results indicate that high endogenous levels of IL-18BP in trangenic mice effectively neutralize IL-18 and are protective in response to different inflammatory stimuli.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12960225     DOI: 10.1189/jlb.0503230

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

1.  IL-18 mediates proapoptotic signaling in renal tubular cells through a Fas ligand-dependent mechanism.

Authors:  Hongji Zhang; Karen L Hile; Hiroshi Asanuma; Brian Vanderbrink; Ethan I Franke; Matthew T Campbell; Kirstan K Meldrum
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

2.  Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

Authors:  Roni Nowarski; Ruaidhrí Jackson; Nicola Gagliani; Marcel R de Zoete; Noah W Palm; Will Bailis; Jun Siong Low; Christian C D Harman; Morven Graham; Eran Elinav; Richard A Flavell
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

3.  β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Authors:  David R Murray; Srinivas Mummidi; Anthony J Valente; Tadashi Yoshida; Naveen K Somanna; Patrice Delafontaine; Charles A Dinarello; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2011-10-08       Impact factor: 5.000

Review 4.  T-cell activation in the intestinal mucosa.

Authors:  Dina Montufar-Solis; Tomas Garza; John R Klein
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

Review 5.  Molecular mechanisms of soluble cytokine receptor generation.

Authors:  Stewart J Levine
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

6.  Disruption of interleukin-18, but not interleukin-1, increases vulnerability to preterm delivery and fetal mortality after intrauterine inflammation.

Authors:  Xiaoyang Wang; Henrik Hagberg; Carina Mallard; Changlian Zhu; Maj Hedtjärn; Carl-Fredrik Tiger; Kristina Eriksson; Asa Rosen; Bo Jacobsson
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

7.  Profibrotic effect of interleukin-18 in HK-2 cells is dependent on stimulation of the Toll-like receptor 4 (TLR4) promoter and increased TLR4 expression.

Authors:  Kirstan K Meldrum; Hongji Zhang; Karen L Hile; Lyle L Moldower; Zizheng Dong; Daniel R Meldrum
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

8.  The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet β cells in vivo and in vitro.

Authors:  Eli C Lewis; Lykke Blaabjerg; Joachim Størling; Sif G Ronn; Paolo Mascagni; Charles A Dinarello; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2010-12-22       Impact factor: 6.354

9.  Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptor.

Authors:  Eli C Lewis; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

10.  IL-18 contributes to renal damage after ischemia-reperfusion.

Authors:  Huiling Wu; Melissa L Craft; Peng Wang; Kate R Wyburn; Gang Chen; Jin Ma; Brett Hambly; Steven J Chadban
Journal:  J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.